TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
HUMAN_PWY-2201	folate transformations I	0.00227517417918563	-6.08569866723057	8	5	0.0381679389312977	131	907	6472,10797,4548,160428,4522	SHMT2,MTHFD2,MTR,ALDH1L2,MTHFD1
META_PWY66-5	superpathway of cholesterol biosynthesis	0.0111662590431649	-4.49485863308267	23	8	0.0610687022900763	131	907	4047,3422,4598,2224,6713,1717,3156,2222	LSS,IDI1,MVK,FDPS,SQLE,DHCR7,HMGCR,FDFT1
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.0190962714259611	-3.95826217628661	25	8	0.0610687022900763	131	907	4047,3422,4598,2224,6713,1717,3156,2222	LSS,IDI1,MVK,FDPS,SQLE,DHCR7,HMGCR,FDFT1
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	2618,5471	GART,PPAT
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	2618,4522	GART,MTHFD1
HUMAN_PROSYN-PWY	proline biosynthesis	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	5832,5831	ALDH18A1,PYCR1
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	2618,5471	GART,PPAT
HUMAN_PWY-5686	UMP biosynthesis	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	790,7372	CAD,UMPS
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	2618,4522	GART,MTHFD1
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	6713,2222	SQLE,FDFT1
META_PROSYN-PWY	L-proline biosynthesis I	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	5832,5831	ALDH18A1,PYCR1
META_PWY-5670	epoxysqualene biosynthesis	0.0207242662538938	-3.87644998250096	2	2	0.0152671755725191	131	907	6713,2222	SQLE,FDFT1
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.0284503469740524	-3.55959492255965	13	5	0.0381679389312977	131	907	790,7372,654364,51727,29922	CAD,UMPS,NME1-NME2,CMPK1,NME7
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	0.0284503469740524	-3.55959492255965	13	5	0.0381679389312977	131	907	2618,654364,3615,5471,471	GART,NME1-NME2,IMPDH2,PPAT,ATIC
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.029183924160649	-3.53413726375556	9	4	0.0305343511450382	131	907	54344,29880,29929,79053	DPM3,ALG5,ALG6,ALG8
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.0562646653985503	-2.87768855368224	3	2	0.0152671755725191	131	907	84693,5095	MCEE,PCCA
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.0562646653985503	-2.87768855368224	3	2	0.0152671755725191	131	907	84693,5095	MCEE,PCCA
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	0.0562646653985503	-2.87768855368224	3	2	0.0152671755725191	131	907	2539,5226	G6PD,PGD
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	0.0562646653985503	-2.87768855368224	3	2	0.0152671755725191	131	907	2539,5226	G6PD,PGD
META_PWY66-341	cholesterol biosynthesis I	0.0606023687892239	-2.80342129773973	11	4	0.0305343511450382	131	907	6713,4047,1717,2222	SQLE,LSS,DHCR7,FDFT1
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.0606023687892239	-2.80342129773973	11	4	0.0305343511450382	131	907	6713,4047,1717,2222	SQLE,LSS,DHCR7,FDFT1
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.0606023687892239	-2.80342129773973	11	4	0.0305343511450382	131	907	6713,4047,1717,2222	SQLE,LSS,DHCR7,FDFT1
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.0663275602930813	-2.71314977747072	7	3	0.0229007633587786	131	907	3145,210,1371	HMBS,ALAD,CPOX
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	0.0663275602930813	-2.71314977747072	7	3	0.0229007633587786	131	907	790,51727,654364	CAD,CMPK1,NME1-NME2
HUMAN_PWY-5920	heme biosynthesis	0.0663275602930813	-2.71314977747072	7	3	0.0229007633587786	131	907	3145,210,1371	HMBS,ALAD,CPOX
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.0810254060674563	-2.51299251833541	12	4	0.0305343511450382	131	907	3422,4598,2224,3156	IDI1,MVK,FDPS,HMGCR
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.0810254060674563	-2.51299251833541	12	4	0.0305343511450382	131	907	3422,4598,2224,3156	IDI1,MVK,FDPS,HMGCR
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	3145,210	HMBS,ALAD
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	8639,314	AOC3,AOC2
META_PWY-7205	CMP phosphorylation	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	654364,51727	NME1-NME2,CMPK1
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	3422,2224	IDI1,FDPS
HUMAN_PWY-2161	folate polyglutamylation	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	6472,4522	SHMT2,MTHFD1
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	3422,2224	IDI1,FDPS
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	6723,4953	SRM,ODC1
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	51805,57107	COQ3,PDSS2
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	3145,210	HMBS,ALAD
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	0.101967888857473	-2.28309733038536	4	2	0.0152671755725191	131	907	51805,57107	COQ3,PDSS2
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.104392098998044	-2.25960128649284	13	4	0.0305343511450382	131	907	6713,4047,1717,2222	SQLE,LSS,DHCR7,FDFT1
HUMAN_PWY66-341	cholesterol biosynthesis I	0.104392098998044	-2.25960128649284	13	4	0.0305343511450382	131	907	6713,4047,1717,2222	SQLE,LSS,DHCR7,FDFT1
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.104392098998044	-2.25960128649284	13	4	0.0305343511450382	131	907	6713,4047,1717,2222	SQLE,LSS,DHCR7,FDFT1
META_PWY66-409	superpathway of purine nucleotide salvage	0.104392098998044	-2.25960128649284	13	4	0.0305343511450382	131	907	3251,654364,3615,132	HPRT1,NME1-NME2,IMPDH2,ADK
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	0.12585500272215	-2.07262480672366	19	5	0.0381679389312977	131	907	10162,57678,253558,56895,84803	LPCAT3,GPAM,LCLAT1,AGPAT4,GPAT3
HUMAN_PWY-6353	purine nucleotides degradation	0.128190815978291	-2.05423537529657	9	3	0.0229007633587786	131	907	3615,51251,4907	IMPDH2,NT5C3A,NT5E
HUMAN_PWY-7205	CMP phosphorylation	0.128190815978291	-2.05423537529657	9	3	0.0229007633587786	131	907	654364,51727,29922	NME1-NME2,CMPK1,NME7
HUMAN_PWY-7527	methionine salvage cycle III	0.128190815978291	-2.05423537529657	9	3	0.0229007633587786	131	907	6723,84245,4144	SRM,MRI1,MAT2A
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.138697525646254	-1.97545979142932	25	6	0.0458015267175573	131	907	10162,57678,64748,253558,56895,84803	LPCAT3,GPAM,PLPPR2,LCLAT1,AGPAT4,GPAT3
HUMAN_P121-PWY	adenine and adenosine salvage I	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	353	APRT
META_PWY-5686	UMP biosynthesis	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	790	CAD
META_PWY-46	putrescine biosynthesis III	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	4953	ODC1
HUMAN_PWY-6898	thiamin salvage III	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	27010	TPK1
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	2582	GALE
HUMAN_PWY-6132	lanosterol biosynthesis	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	4047	LSS
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	2582	GALE
HUMAN_SERDEG-PWY	L-serine degradation	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	113675	SDSL
META_PWY-6619	adenine and adenosine salvage VI	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	132	ADK
HUMAN_PWY66-366	flavin biosynthesis	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	80308	FLAD1
META_PWY-7344	UDP-D-galactose biosynthesis	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	2582	GALE
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	6723	SRM
META_PWY-6132	lanosterol biosynthesis	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	4047	LSS
HUMAN_PWY-46	putrescine biosynthesis I	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	4953	ODC1
HUMAN_MANNCAT-PWY	D-mannose degradation	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	4351	MPI
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	7264	TSTA3
HUMAN_PWY-6619	adenine and adenosine salvage II	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	132	ADK
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	0.144432194046446	-1.93494512691302	1	1	0.00763358778625954	131	907	6723	SRM
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.14926946707716	-1.90200210253724	20	5	0.0381679389312977	131	907	790,7372,654364,51727,29922	CAD,UMPS,NME1-NME2,CMPK1,NME7
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.151305516052248	-1.8884542011376	37	8	0.0610687022900763	131	907	654364,2618,204,29922,5471,471,3615,513	NME1-NME2,GART,AK2,NME7,PPAT,ATIC,IMPDH2,ATP5D
HUMAN_PWY-3661-1	glycine betaine degradation	0.154200144238778	-1.86950388245271	5	2	0.0152671755725191	131	907	29958,6472	DMGDH,SHMT2
META_PWY-3661-1	glycine betaine degradation II (mammalian)	0.154200144238778	-1.86950388245271	5	2	0.0152671755725191	131	907	29958,6472	DMGDH,SHMT2
META_PWY-6111	mitochondrial L-carnitine shuttle	0.154200144238778	-1.86950388245271	5	2	0.0152671755725191	131	907	1374,126129	CPT1A,CPT1C
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	0.154200144238778	-1.86950388245271	5	2	0.0152671755725191	131	907	1374,126129	CPT1A,CPT1C
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.154200144238778	-1.86950388245271	5	2	0.0152671755725191	131	907	654364,51727	NME1-NME2,CMPK1
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.154200144238778	-1.86950388245271	5	2	0.0152671755725191	131	907	3615,4907	IMPDH2,NT5E
META_PWY-922	mevalonate pathway I	0.164574194931578	-1.80439377744282	10	3	0.0229007633587786	131	907	3422,4598,3156	IDI1,MVK,HMGCR
HUMAN_PWY-922	mevalonate pathway	0.164574194931578	-1.80439377744282	10	3	0.0229007633587786	131	907	3422,4598,3156	IDI1,MVK,HMGCR
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	0.164574194931578	-1.80439377744282	10	3	0.0229007633587786	131	907	654364,51727,29922	NME1-NME2,CMPK1,NME7
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	0.169406273226346	-1.77545546541711	38	8	0.0610687022900763	131	907	3251,654364,204,29922,353,3615,132,513	HPRT1,NME1-NME2,AK2,NME7,APRT,IMPDH2,ADK,ATP5D
META_PWY66-398	TCA cycle III (animals)	0.18940668533676	-1.66385880140452	16	4	0.0305343511450382	131	907	8801,8802,1743,3421	SUCLG2,SUCLG1,DLST,IDH3G
HUMAN_PWY66-398	TCA cycle	0.18940668533676	-1.66385880140452	16	4	0.0305343511450382	131	907	8801,8802,1743,3421	SUCLG2,SUCLG1,DLST,IDH3G
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.203563629735136	-1.59177664614156	11	3	0.0229007633587786	131	907	654364,3615,29922	NME1-NME2,IMPDH2,NME7
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.203563629735136	-1.59177664614156	11	3	0.0229007633587786	131	907	8871,3628,8867	SYNJ2,INPP1,SYNJ1
HUMAN_LIPAS-PWY	triacylglycerol degradation	0.203563629735136	-1.59177664614156	11	3	0.0229007633587786	131	907	8228,11343,57406	PNPLA4,MGLL,ABHD6
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	0.203563629735136	-1.59177664614156	11	3	0.0229007633587786	131	907	654364,51727,29922	NME1-NME2,CMPK1,NME7
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	0.210152934440693	-1.55991975407536	6	2	0.0152671755725191	131	907	654364,3615	NME1-NME2,IMPDH2
META_PWY-7176	UTP and CTP de novo biosynthesis	0.210152934440693	-1.55991975407536	6	2	0.0152671755725191	131	907	654364,51727	NME1-NME2,CMPK1
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	0.210152934440693	-1.55991975407536	6	2	0.0152671755725191	131	907	3615,4907	IMPDH2,NT5E
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	0.210152934440693	-1.55991975407536	6	2	0.0152671755725191	131	907	2539,5226	G6PD,PGD
META_PWY-6857	retinol biosynthesis	0.244409704291537	-1.40890934587913	12	3	0.0229007633587786	131	907	5947,157506,51109	RBP1,RDH10,RDH11
HUMAN_PWY66-374	C20 prostanoid biosynthesis	0.267683084100217	-1.31795152021624	7	2	0.0152671755725191	131	907	5742,6916	PTGS1,TBXAS1
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	0.267683084100217	-1.31795152021624	7	2	0.0152671755725191	131	907	51251,4907	NT5C3A,NT5E
META_PWY66-374	C20 prostanoid biosynthesis	0.267683084100217	-1.31795152021624	7	2	0.0152671755725191	131	907	5742,6916	PTGS1,TBXAS1
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	0.267683084100217	-1.31795152021624	7	2	0.0152671755725191	131	907	51447,23262	IP6K2,PPIP5K2
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	0.267683084100217	-1.31795152021624	7	2	0.0152671755725191	131	907	29958,6472	DMGDH,SHMT2
META_PWY-5130	2-oxobutanoate degradation I	0.267683084100217	-1.31795152021624	7	2	0.0152671755725191	131	907	84693,5095	MCEE,PCCA
META_PWY-6369	inositol pyrophosphates biosynthesis	0.267683084100217	-1.31795152021624	7	2	0.0152671755725191	131	907	51447,23262	IP6K2,PPIP5K2
HUMAN_PWY-5130	2-oxobutanoate degradation	0.267683084100217	-1.31795152021624	7	2	0.0152671755725191	131	907	84693,5095	MCEE,PCCA
META_PWY-6620	guanine and guanosine salvage	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	3251	HPRT1
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	79644	SRD5A3
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	7378	UPP1
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	80308	FLAD1
HUMAN_PWY6666-1	anandamide degradation	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	158584	FAAH2
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	55253	TYW1
HUMAN_PWY-6620	guanine and guanosine salvage	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	3251	HPRT1
HUMAN_PWY-5525	D-glucuronate degradation	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	51181	DCXR
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	3939	LDHA
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	11019	LIAS
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	2744	GLS
META_PWY-5030	L-histidine degradation III	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	4522	MTHFD1
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	57107	PDSS2
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	471	ATIC
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	6472	SHMT2
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	471	ATIC
HUMAN_PWY-4041	gamma-glutamyl cycle	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	55748	CNDP2
HUMAN_PWY-6482	diphthamide biosynthesis	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	89978	DPH6
META_SERDEG-PWY	L-serine degradation	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	113675	SDSL
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	6472	SHMT2
HUMAN_PWY-1801	formaldehyde oxidation	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	128	ADH5
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.26814012183444	-1.31624559244006	2	1	0.00763358778625954	131	907	440	ASNS
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.286414985879883	-1.25031352026496	13	3	0.0229007633587786	131	907	790,654364,51727	CAD,NME1-NME2,CMPK1
META_PWY-6861	the visual cycle I (vertebrates)	0.286414985879883	-1.25031352026496	13	3	0.0229007633587786	131	907	5947,157506,51109	RBP1,RDH10,RDH11
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	0.286414985879883	-1.25031352026496	13	3	0.0229007633587786	131	907	8871,3628,8867	SYNJ2,INPP1,SYNJ1
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	0.325181272565281	-1.12337249040434	8	2	0.0152671755725191	131	907	654364,3615	NME1-NME2,IMPDH2
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	0.328949925279385	-1.11184974259901	14	3	0.0229007633587786	131	907	654364,3615,29922	NME1-NME2,IMPDH2,NME7
HUMAN_PWY-5328	superpathway of methionine degradation	0.328949925279385	-1.11184974259901	14	3	0.0229007633587786	131	907	84693,5095,4144	MCEE,PCCA,MAT2A
META_PWY-5328	superpathway of L-methionine salvage and degradation	0.328949925279385	-1.11184974259901	14	3	0.0229007633587786	131	907	84693,4548,5095	MCEE,MTR,PCCA
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.37146104892412	-0.990311268439386	15	3	0.0229007633587786	131	907	5947,157506,51109	RBP1,RDH10,RDH11
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.37146104892412	-0.990311268439386	15	3	0.0229007633587786	131	907	654364,51727,29922	NME1-NME2,CMPK1,NME7
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	4548	MTR
META_PWY-6609	adenine and adenosine salvage III	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	3251	HPRT1
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	1743	DLST
META_ARGININE-SYN4-PWY	L-ornithine de novo  biosynthesis	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	5832	ALDH18A1
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	7378	UPP1
HUMAN_PWY-6875	retinoate biosynthesis II	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	5947	RBP1
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	4548	MTR
HUMAN_PWY-6100	L-carnitine biosynthesis	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	55217	TMLHE
META_PWY-6875	retinoate biosynthesis II	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	5947	RBP1
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	1743	DLST
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	4144	MAT2A
META_PWY-6100	L-carnitine biosynthesis	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	55217	TMLHE
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	6472	SHMT2
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	10135	NAMPT
META_PWY-7527	L-methionine salvage cycle III	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	6723	SRM
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	1371	CPOX
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	5831	PYCR1
HUMAN_PWY-6609	adenine and adenosine salvage III	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	3251	HPRT1
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	5832	ALDH18A1
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	1371	CPOX
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	4144	MAT2A
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	3141	HLCS
HUMAN_PWY-7283	wybutosine biosynthesis	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	55253	TYW1
META_PWY66-422	D-galactose degradation V (Leloir pathway)	0.374077850057793	-0.983291347994159	3	1	0.00763358778625954	131	907	2582	GALE
META_PWY-6353	purine nucleotides degradation II (aerobic)	0.381464260162243	-0.963738115051751	9	2	0.0152671755725191	131	907	3615,4907	IMPDH2,NT5E
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.435686776471006	-0.830831696397336	10	2	0.0152671755725191	131	907	654364,29922	NME1-NME2,NME7
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.435686776471006	-0.830831696397336	10	2	0.0152671755725191	131	907	654364,51727	NME1-NME2,CMPK1
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	0.435686776471006	-0.830831696397336	10	2	0.0152671755725191	131	907	654364,29922	NME1-NME2,NME7
HUMAN_PWY-6857	retinol biosynthesis	0.454590249392416	-0.788358816556556	17	3	0.0229007633587786	131	907	5947,157506,51109	RBP1,RDH10,RDH11
META_PWY-6823	molybdenum cofactor biosynthesis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	10243	GPHN
META_PWY66-368	ketolysis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	56898	BDH2
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	5210	PFKFB4
META_PWY-7434	terminal O-glycans residues modification	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	2651	GCNT2
HUMAN_PWY-6117	spermine and spermidine degradation I	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	8639	AOC3
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	84245	MRI1
HUMAN_PWY66-368	ketolysis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	56898	BDH2
HUMAN_PWY-5659	GDP-mannose biosynthesis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	4351	MPI
HUMAN_PWY-6292	cysteine biosynthesis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	4144	MAT2A
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	2992	GYG1
HUMAN_PWY66-367	ketogenesis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	56898	BDH2
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	84245	MRI1
META_PWY66-162	ethanol degradation IV	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	847	CAT
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	7378	UPP1
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	5210	PFKFB4
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	6472	SHMT2
HUMAN_PWY-5874	heme degradation	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	3163	HMOX2
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	2941	GSTA4
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	10243	GPHN
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	0.464781170459664	-0.766188585324273	4	1	0.00763358778625954	131	907	5831	PYCR1
HUMAN_PWY-5972	stearate biosynthesis	0.487269697967892	-0.718937514591923	11	2	0.0152671755725191	131	907	51703,79071	ACSL5,ELOVL6
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	0.487269697967892	-0.718937514591923	11	2	0.0152671755725191	131	907	654364,29922	NME1-NME2,NME7
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.532908897495129	-0.629404793449616	19	3	0.0229007633587786	131	907	8871,3628,8867	SYNJ2,INPP1,SYNJ1
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.535841696703908	-0.623916503503685	12	2	0.0152671755725191	131	907	51703,51	ACSL5,ACOX1
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	0.535841696703908	-0.623916503503685	12	2	0.0152671755725191	131	907	10998,80270	SLC27A5,HSD3B7
META_PWY-5667	CDP-diacylglycerol biosynthesis I	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	56895	AGPAT4
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	654364	NME1-NME2
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	7378	UPP1
HUMAN_PWY66-375	leukotriene biosynthesis	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	1800	DPEP1
META_CITRULBIO-PWY	L-citrulline biosynthesis	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	5832	ALDH18A1
META_PWY66-375	leukotriene biosynthesis	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	1800	DPEP1
META_PWY-6566	chondroitin biosynthesis	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	55454	CSGALNACT2
HUMAN_PWY-6566	chondroitin and dermatan biosynthesis	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	55454	CSGALNACT2
HUMAN_COA-PWY-1	coenzyme A biosynthesis	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	60490	PPCDC
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	4907	NT5E
HUMAN_PWY66-162	ethanol degradation IV	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	847	CAT
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	151230	KLHL23
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	2582	GALE
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	60490	PPCDC
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	654364	NME1-NME2
HUMAN_PWY-5030	histidine degradation	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	4522	MTHFD1
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	0.542426427016371	-0.611702821167532	5	1	0.00763358778625954	131	907	7378	UPP1
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	0.56966091015745	-0.562713989634074	20	3	0.0229007633587786	131	907	8871,3628,8867	SYNJ2,INPP1,SYNJ1
HUMAN_PWY-6368	3-phosphoinositide degradation	0.56966091015745	-0.562713989634074	20	3	0.0229007633587786	131	907	8871,8867,23203	SYNJ2,SYNJ1,PMPCA
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.581192007763545	-0.542674098647687	13	2	0.0152671755725191	131	907	50515,55454	CHST11,CSGALNACT2
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.581192007763545	-0.542674098647687	13	2	0.0152671755725191	131	907	5298,5305	PI4KB,PIP4K2A
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	0.581192007763545	-0.542674098647687	13	2	0.0152671755725191	131	907	51703,51	ACSL5,ACOX1
META_PWY66-428	L-threonine degradation V	0.608881125533206	-0.496132226494284	6	1	0.00763358778625954	131	907	113675	SDSL
META_PWY-5972	stearate biosynthesis I (animals and fungi)	0.608881125533206	-0.496132226494284	6	1	0.00763358778625954	131	907	79071	ELOVL6
HUMAN_PWY-5143	fatty acid activation	0.608881125533206	-0.496132226494284	6	1	0.00763358778625954	131	907	51703	ACSL5
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	0.608881125533206	-0.496132226494284	6	1	0.00763358778625954	131	907	654364	NME1-NME2
META_ILEUDEG-PWY	L-isoleucine degradation I	0.608881125533206	-0.496132226494284	6	1	0.00763358778625954	131	907	3028	HSD17B10
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	0.608881125533206	-0.496132226494284	6	1	0.00763358778625954	131	907	7378	UPP1
HUMAN_PWY66-428	threonine degradation	0.608881125533206	-0.496132226494284	6	1	0.00763358778625954	131	907	113675	SDSL
META_PWY-5327	superpathway of L-lysine degradation	0.608881125533206	-0.496132226494284	6	1	0.00763358778625954	131	907	35	ACADS
META_FAO-PWY	fatty acid beta-oxidation I	0.623232354844454	-0.472835868500382	14	2	0.0152671755725191	131	907	51703,3028	ACSL5,HSD17B10
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	0.623232354844454	-0.472835868500382	14	2	0.0152671755725191	131	907	654364,29922	NME1-NME2,NME7
HUMAN_FAO-PWY	fatty acid beta-oxidation	0.623232354844454	-0.472835868500382	14	2	0.0152671755725191	131	907	51703,3028	ACSL5,HSD17B10
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.623232354844454	-0.472835868500382	14	2	0.0152671755725191	131	907	654364,29922	NME1-NME2,NME7
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.633961350078513	-0.455767288424444	66	9	0.0687022900763359	131	907	5298,30849,51259,51447,8871,23262,8867,5291,5305	PI4KB,PIK3R4,TMEM216,IP6K2,SYNJ2,PPIP5K2,SYNJ1,PIK3CB,PIP4K2A
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.661966401910279	-0.412540476734466	15	2	0.0152671755725191	131	907	8871,8867	SYNJ2,SYNJ1
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	0.661966401910279	-0.412540476734466	15	2	0.0152671755725191	131	907	8871,8867	SYNJ2,SYNJ1
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.661966401910279	-0.412540476734466	15	2	0.0152671755725191	131	907	8871,8867	SYNJ2,SYNJ1
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	0.661966401910279	-0.412540476734466	15	2	0.0152671755725191	131	907	8871,8867	SYNJ2,SYNJ1
META_LEU-DEG2-PWY	L-leucine degradation I	0.665747465773838	-0.406844860868621	7	1	0.00763358778625954	131	907	549	AUH
META_PWY-6872	retinoate biosynthesis I	0.665747465773838	-0.406844860868621	7	1	0.00763358778625954	131	907	5947	RBP1
META_PWY-7224	purine deoxyribonucleosides salvage	0.665747465773838	-0.406844860868621	7	1	0.00763358778625954	131	907	654364	NME1-NME2
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	0.665747465773838	-0.406844860868621	7	1	0.00763358778625954	131	907	50515	CHST11
HUMAN_PWY66-373	sucrose degradation	0.665747465773838	-0.406844860868621	7	1	0.00763358778625954	131	907	26007	TKFC
HUMAN_PWY-5067	glycogen biosynthesis	0.665747465773838	-0.406844860868621	7	1	0.00763358778625954	131	907	2992	GYG1
META_DETOX1-PWY-1	reactive oxygen species degradation	0.665747465773838	-0.406844860868621	7	1	0.00763358778625954	131	907	847	CAT
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.668733747194536	-0.402369284327757	23	3	0.0229007633587786	131	907	5298,5305,51259	PI4KB,PIP4K2A,TMEM216
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.714399779090483	-0.336312558643743	8	1	0.00763358778625954	131	907	4247	MGAT2
HUMAN_PWY-7434	terminal O-glycans residues modification	0.714399779090483	-0.336312558643743	8	1	0.00763358778625954	131	907	2651	GCNT2
HUMAN_PWY-6872	retinoate biosynthesis I	0.714399779090483	-0.336312558643743	8	1	0.00763358778625954	131	907	5947	RBP1
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	0.714399779090483	-0.336312558643743	8	1	0.00763358778625954	131	907	2582	GALE
META_PWY-6352	3-phosphoinositide biosynthesis	0.725014721718414	-0.321563318515121	25	3	0.0229007633587786	131	907	5298,5291,30849	PI4KB,PIK3CB,PIK3R4
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.72984872442149	-0.314917993134021	17	2	0.0152671755725191	131	907	5305,51259	PIP4K2A,TMEM216
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.756016718959103	-0.27969178802187	9	1	0.00763358778625954	131	907	654364	NME1-NME2
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.756016718959103	-0.27969178802187	9	1	0.00763358778625954	131	907	5305	PIP4K2A
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	0.756016718959103	-0.27969178802187	9	1	0.00763358778625954	131	907	654364	NME1-NME2
META_PWY-6569	chondroitin sulfate biosynthesis	0.759268906935931	-0.275399273244592	18	2	0.0152671755725191	131	907	50515,55454	CHST11,CSGALNACT2
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.773623310103225	-0.256670203312491	27	3	0.0229007633587786	131	907	5298,5291,30849	PI4KB,PIK3CB,PIK3R4
HUMAN_PWY-4061	glutathione-mediated detoxification	0.785899496282468	-0.240926362053758	19	2	0.0152671755725191	131	907	2941,4257	GSTA4,MGST1
META_PWY-6368	3-phosphoinositide degradation	0.785899496282468	-0.240926362053758	19	2	0.0152671755725191	131	907	8871,8867	SYNJ2,SYNJ1
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.785899496282468	-0.240926362053758	19	2	0.0152671755725191	131	907	50515,55454	CHST11,CSGALNACT2
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.785899496282468	-0.240926362053758	19	2	0.0152671755725191	131	907	204,513	AK2,ATP5D
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	0.791608934793401	-0.233687778312117	10	1	0.00763358778625954	131	907	847	CAT
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.791608934793401	-0.233687778312117	10	1	0.00763358778625954	131	907	51703	ACSL5
META_PWY-5004	superpathway of L-citrulline metabolism	0.82204285847633	-0.195962746019553	11	1	0.00763358778625954	131	907	5832	ALDH18A1
HUMAN_LEU-DEG2-PWY	leucine degradation	0.82204285847633	-0.195962746019553	11	1	0.00763358778625954	131	907	549	AUH
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.824512825201284	-0.192962581977588	38	4	0.0305343511450382	131	907	8801,8802,1743,3421	SUCLG2,SUCLG1,DLST,IDH3G
HUMAN_VALDEG-PWY	valine degradation	0.848061145912141	-0.16480253976128	12	1	0.00763358778625954	131	907	26275	HIBCH
HUMAN_ILEUDEG-PWY	isoleucine degradation	0.848061145912141	-0.16480253976128	12	1	0.00763358778625954	131	907	3028	HSD17B10
HUMAN_PWY-6000	gamma-linolenate biosynthesis	0.848061145912141	-0.16480253976128	12	1	0.00763358778625954	131	907	51703	ACSL5
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.897578616600634	-0.10805456735773	25	2	0.0152671755725191	131	907	55568,374378	GALNT10,GALNT18
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.905543967102028	-0.0992194472305758	15	1	0.00763358778625954	131	907	55454	CSGALNACT2
META_PWY-6571	dermatan sulfate biosynthesis	0.905543967102028	-0.0992194472305758	15	1	0.00763358778625954	131	907	55454	CSGALNACT2
HUMAN_LIPASYN-PWY	phospholipases	0.938959401958871	-0.0629830361091145	29	2	0.0152671755725191	131	907	81579,51259	PLA2G12A,TMEM216
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6076	vitamin D3 biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY0-662	PRPP biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6117	spermine and spermidine degradation I	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-4041	gamma-glutamyl cycle	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY66-397	resolvin D biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-5340	sulfate activation for sulfonation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-5874	heme degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY3O-4106	NAD salvage pathway III	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-5905	hypusine biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-7511	protein ubiquitylation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6118	glycerol-3-phosphate shuttle	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY66-14	MAP kinase cascade	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-5340	sulfate activation for sulfonation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-5386	methylglyoxal degradation I	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6181	histamine degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY0-662	PRPP biosynthesis I	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-5177	glutaryl-CoA degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_GLUDEG-I-PWY	GABA shunt	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6145	superpathway of sialic acids and CMP-sialic acids biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY66-388	fatty acid alpha-oxidation III	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-5453	methylglyoxal degradation III	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PROUT-PWY	L-proline degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-7306	estradiol biosynthesis II	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-7343	UDP-glucose biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6370	ascorbate recycling (cytosolic)	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
HUMAN_PWY-6608	guanosine nucleotides degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY-6181	histamine degradation	0.999999999995127	-4.87331702769822e-12	2	0	0	131	907
META_PWY66-382	mineralocorticoid biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-5996	oleate biosynthesis II (animals and fungi)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-5331	taurine biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-5664	tetrahydrobiopterin biosynthesis II	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY66-381	glucocorticoid biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-5331	taurine biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_GLYCLEAV-PWY	glycine cleavage	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY66-392	lipoxin biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY6666-2	dopamine degradation	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY66-382	mineralocorticoid biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-6430	thymine degradation	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY66-381	glucocorticoid biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY66-301	catecholamine biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY0-1296	purine ribonucleosides degradation	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-3982	uracil degradation	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-0	putrescine degradation III	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY0-1182	trehalose degradation	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-5451	acetone degradation I (to methylglyoxal)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-5663	tetrahydrobiopterin biosynthesis I	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-2301	myo-inositol biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-7193	pyrimidine ribonucleosides salvage I	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-7177	UTP and CTP dephosphorylation II	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-4202	arsenate detoxification I (glutaredoxin)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-3982	uracil degradation I (reductive)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_GLUDEG-I-PWY	GABA shunt	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-5453	methylglyoxal degradation III	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY66-221	nicotine degradation V	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY66-392	lipoxin biosynthesis	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
META_PWY-7185	UTP and CTP dephosphorylation I	0.999999999999057	-9.43053794777438e-13	3	0	0	131	907
HUMAN_PWY6666-2	dopamine degradation	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-6158	creatine-phosphate biosynthesis	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-3781	aerobic respiration I (cytochrome c)	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY66-21	ethanol degradation II	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-5177	glutaryl-CoA degradation	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-6158	creatine-phosphate biosynthesis	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-4921	protein citrullination	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-6608	guanosine nucleotides degradation III	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY66-161	oxidative ethanol degradation III	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-5661	GDP-glucose biosynthesis	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY66-387	fatty acid alpha-oxidation	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-6061	bile acid biosynthesis, neutral pathway	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-4984	urea cycle	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-6307	tryptophan degradation via tryptamine	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-4261	glycerol degradation	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY66-387	fatty acid alpha-oxidation II	0.999999999999313	-6.8656061738559e-13	4	0	0	131	907
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6133	(S)-reticuline biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY66-421	homocarnosine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5329	L-cysteine degradation III	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6273	phosphatidylethanolamine biosynthesis III	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-5148	acyl-CoA hydrolysis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6399	melatonin degradation II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5905	hypusine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5966	fatty acid biosynthesis initiation II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY0-522	lipoate salvage	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6377	alpha-tocopherol degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_GLYCGREAT-PWY	creatine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5326	sulfite oxidation IV	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY66-389	phytol degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_BGALACT-PWY	lactose degradation III	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-40	putrescine biosynthesis II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7506	phosphatidylserine biosynthesis II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6012-1	acyl carrier protein metabolism II (mammalian)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6938	NADH repair	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PROUT-PWY	proline degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7299	progesterone biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-5326	sulfite oxidation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY0-1305	glutamate dependent acid resistance	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_GLNSYN-PWY	L-glutamine biosynthesis I	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-4101	sorbitol degradation I	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-40	putrescine biosynthesis I	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7306	estradiol biosynthesis II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-7299	progesterone biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY66-421	homocarnosine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7592	arachidonate biosynthesis III (metazoa)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5766	L-glutamate degradation X	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6173	histamine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY66-241	bupropion degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY66-420	carnosine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_HISHP-PWY	L-histidine degradation VI	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_ARGSPECAT-PWY	spermine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_ALANINE-DEG3-PWY	L-alanine degradation III	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6938	NADH repair	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY6666-1	anandamide degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY66-420	carnosine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6535	4-aminobutyrate degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6173	histamine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6481	L-dopachrome biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-5329	L-cysteine degradation II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY0-1313	acetate conversion to acetyl-CoA	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6377	alpha-tocopherol degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY0-1021	L-alanine biosynthesis III	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6134	L-tyrosine biosynthesis IV	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation II (mammalian)	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_GLNSYN-PWY	glutamine biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-5269	cardiolipin biosynthesis II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY66-389	phytol degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6481	L-dopachrome biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6241	thyroid hormone biosynthesis	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6535	4-aminobutanoate degradation I	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-6334	L-dopa degradation	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY66-11	BMP Signalling Pathway	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY-2161B	glutamate removal from folates	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
META_PWY-6133	(S)-reticuline biosynthesis II	1.00000000000022	2.22544205286113e-13	1	0	0	131	907
HUMAN_PWY66-380	estradiol biosynthesis I	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY-4983	citrulline-nitric oxide cycle	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_TYRFUMCAT-PWY	L-tyrosine degradation I	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY66-367	ketogenesis	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-6313	serotonin degradation	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-6074	zymosterol biosynthesis	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-6398	melatonin degradation I	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-4983	L-citrulline-nitric oxide cycle	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_VALDEG-PWY	L-valine degradation I	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-6402	superpathway of melatonin degradation	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY66-201	nicotine degradation IV	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY66-21	ethanol degradation II	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-4061	glutathione-mediated detoxification I	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY66-241	bupropion degradation	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-4921	protein citrullination	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-4984	urea cycle	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
META_PWY-4081	glutathione redox reactions I	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	1.00000000000049	4.8770551806061e-13	5	0	0	131	907
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
META_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
META_PWY66-378	androgen biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
META_PWY3DJ-12	ceramide de novo biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY-5996	oleate biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY-6074	zymosterol biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY66-161	oxidative ethanol degradation III	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY66-378	androgen biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY-7455	allopregnanolone biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
META_PWY-7455	allopregnanolone biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY-4081	glutathione redox reactions I	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
META_PWY-7277	sphingolipid biosynthesis (mammals)	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	1.00000000000191	1.9097039047507e-12	6	0	0	131	907
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	1.00000000000357	3.57270959532721e-12	7	0	0	131	907
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000357	3.57270959532721e-12	7	0	0	131	907
HUMAN_PWY66-221	nicotine degradation III	1.00000000000357	3.57270959532721e-12	7	0	0	131	907
HUMAN_PWY-5994	palmitate biosynthesis	1.00000000000357	3.57270959532721e-12	7	0	0	131	907
HUMAN_PWY-6313	serotonin degradation	1.00000000000357	3.57270959532721e-12	7	0	0	131	907
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	1.00000000000479	4.79059952744343e-12	8	0	0	131	907
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	1.00000000000479	4.79059952744343e-12	8	0	0	131	907
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	1.00000000000479	4.79059952744343e-12	8	0	0	131	907
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	1.00000000000726	7.25622993259945e-12	9	0	0	131	907
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	1.00000000000726	7.25622993259945e-12	9	0	0	131	907
HUMAN_PWY-0	putrescine degradation III	1.00000000000726	7.25622993259945e-12	9	0	0	131	907
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	1.00000000000726	7.25622993259945e-12	9	0	0	131	907
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	1.0000000000093	9.30159286255013e-12	10	0	0	131	907
HUMAN_PWY-6398	melatonin degradation I	1.0000000000093	9.30159286255013e-12	10	0	0	131	907
HUMAN_PWY66-201	nicotine degradation IV	1.0000000000093	9.30159286255013e-12	10	0	0	131	907
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000945	9.44668319794735e-12	11	0	0	131	907
HUMAN_PWY-6309	L-kynurenine degradation	1.00000000000945	9.44668319794735e-12	11	0	0	131	907
HUMAN_PWY-6402	superpathway of melatonin degradation	1.00000000000945	9.44668319794735e-12	11	0	0	131	907
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	1.00000000000945	9.44668319794735e-12	11	0	0	131	907
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000001359	1.35944015255859e-11	14	0	0	131	907
META_ANAEROFRUCAT-PWY	homolactic fermentation	1.0000000000159	1.59023763632622e-11	15	0	0	131	907
HUMAN_PWY66-399	gluconeogenesis	1.00000000001664	1.66391570698567e-11	16	0	0	131	907
META_PWY66-399	gluconeogenesis III	1.00000000001664	1.66391570698567e-11	16	0	0	131	907
META_PWY66-400	glycolysis VI (metazoan)	1.00000000001881	1.88105815329353e-11	17	0	0	131	907
META_PWY-6558	heparan sulfate biosynthesis (late stages)	1.00000000001881	1.88105815329353e-11	17	0	0	131	907
HUMAN_PWY66-400	glycolysis	1.00000000001881	1.88105815329353e-11	17	0	0	131	907
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	1.00000000002252	2.25230841790215e-11	20	0	0	131	907
META_PWY-6564	heparan sulfate biosynthesis	1.00000000002389	2.38896803560597e-11	23	0	0	131	907
HUMAN_PWY-6564	heparan sulfate biosynthesis	1.00000000002801	2.80136063617027e-11	26	0	0	131	907
HUMAN_PWY-7511	protein ubiquitylation	1.00000000003041	3.04119092688793e-11	28	0	0	131	907
HUMAN_PWY66-401	superpathway of tryptophan utilization	1.00000000003369	3.36884030811572e-11	34	0	0	131	907
